Dashboard
$CYABJul 9, 2026, 12:00 PMAI processed

Cyabra prices ~$6.0M private placement for ~13.82M shares with attached warrants

AI Summary

Cyabra agreed to sell 13,818,770 shares of common stock (or equivalents) at $0.435 per share in a private placement, with Series A warrants to buy up to 13,818,770 shares ($0.50 strike, 5‐yr) and Series B warrants to buy up to 13,818,770 shares ($0.45 strike, 12‐mo). Gross proceeds are expected to be about $6.0M before fees; A.G.P./Alliance Global Partners is the sole placement agent and the company will file a resale registration statement covering the shares and warrants. Closing is expected on or about July 10, 2026 (dilution from the private placement occurs at closing); the conversion of outstanding preferred into 35,648,276 common shares and the exercisability of the warrants are subject to stockholder approval, so that additional dilution is contingent on that approval. Timing: Public-market dilution depends on another filing or resale step first, and the press release does not say when that will be completed.

Positives

  • Existing management, board members and new institutional investors are participating
  • Company will file a registration statement to enable resale of the private placement shares and warrants

Negatives

  • Large conditional preferred conversion would add 35,648,276 common shares if stockholders approve
  • Warrants cover up to 13,818,770 shares each (Series A and Series B), creating additional potential overhang
  • Securities issued under Reg D exemption and initially unregistered (resale restrictions until registration effective)

Filing Context

Filing and Dilution Context

Earliest dilution

Earliest dilution: another filing needed

Dilution status

conditional

Dilution timing

Dilution status: Undetermined

Trigger type

filing_needed